Advanced search
Publication Cover
Gynecological Endocrinology Volume 23, 2007 - Issue 5
Submit an article Journal homepage
154
Views
8
CrossRef citations to date
0
Altmetric
CaseReport

A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2

Seung-Hwan Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea
,
Mee-Ran Kim Department of Obstetrics and Gynecology, The Catholic University of Korea, Seoul, South Korea
,
Ji-Hyun Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea
,
Hyuk-Sang Kwon Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea
,
Kun-Ho Yoon Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea
,
Ho-Young Son Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South Korea
&
Bong-Yun Cha Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, South KoreaCorrespondence[email protected]
 show all
Pages 252-256 | Received 26 Sep 2006, Accepted 21 Feb 2007, Published online: 07 Jul 2009

References

  • Neufeld M, Blizzard R M. Polyglandular autoimmune diseases. Symposium on autoimmune aspects of endocrine disorders, A Pinchera, D Doniach, G F Fenzi, L Basschieri. Academic Press, New York 1980; 357–365
  • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
  • Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H F, Futterweit W, Janssen O E, Legro R S, Norman R J, Taylor A E, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237–4245
  • Zawadski J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome, A Dunaif, J R Givens, F P Haseltine, G R Merriam. Blackwell Scientific Publications, Boston (MA) 1992; 377–384
  • Ehrmann D A, Barnes R B, Rosenfield R L, Cavaghan M K, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141–146
  • Escobar-Morreale H F, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, García-Robles R. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2000; 85: 4182–4187
  • Codner E, Soto N, Lopez P, Trejo L, Ávila A, Eyzaguirre F C, Íniguez G, Cassorla F. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006; 91: 2250–2256
  • Pedersen O, Beck-Nielsen H. Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 1987; 10: 516–523
  • Ehrmann D A. Polycystic ovary syndrome. N Engl J Med 2005; 352: 1223–1236
  • Ykijarvinen H, Makimattila S, Utriainen T, Rutanen E M. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995; 80: 3227–3232
  • Janssen O E, Mehlmauer N, Hahn S, Őffner A H, Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004; 150: 363–369
  • Olsen N J, Kovacs W J. Effects of androgens on T and B lymphocyte development. Immunol Res 2001; 23: 281–288
  • Paavonen T. Hormonal regulation of immune responses. Ann Med 1994; 26: 255–258
  • Ghosh S, Kabir S N, Pakrashi A, Chatterjee S, Chakravarty B. Subclinical hypothyroidism: a determinant of polycystic ovary syndrome. Horm Res 1994; 41: 43–44
  • Hoek A, Schoemaker J, Drexhage H A. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107–134
  • Fénichel P, Gobert B, Carré Y, Barbarino-Monnier P, Hiéronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet 1999; 353: 2210
  • van Gelderen C J, Gomes dos Santos M L. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med 1993; 38: 381–386
  • Rojansky N, Roll D, Meirow D. Polycystic ovary syndrome. An autoimmune disease?. J Reprod Med 1997; 42: 325–328
  • Reimand K, Talja I, Metsküla K, Kadastik Ü, Matt K, Uibo R. Autoantibody studies of female patients with reproductive failure. J Reprod Immunol 2001; 51: 167–176
  • Cela E, Robertson C, Rush K, Kousta E, White D M, Wilson H, Lyons G, Kingsley P, McCarthy M I, Franks S. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol 2003; 149: 439–442
  • Yildiz B O. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 2006; 20: 167–176
  • Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kampe O. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type 1. Biochem Biophys Res Commun 2000; 267: 456–461
  • Gordon G G, Southren A I, Calanog A, Olivo J, Rafii F. The effect of medroxyprogesterone acetate on androgen metabolism in the polycystic ovary syndrome. J Clin Endocrinol Metab 1972; 35: 444–447
  • Roldán B, Escobar-Morreale H F, Barrio R, de la Calle H, Alonso M, García-Robles R, Sancho J. Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 2001; 24: 1297–1299
  • Virdis R, Zampolli M, Street M E, Vanelli M, Potau N, Terzi C, Ghizzoni L, Ibanez L. Ovarian 17α-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents. Eur J Endocrinol 1997; 136: 624–629

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.